#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency Renal transplant Vitamin B12 deficiency Neuropathy peripheral Anaplastic thyroid cancer Metastatic malignant melanoma White matter lesion Advanced systemic mastocytosis Eosinophilic oesophagitis Ventricular fibrillation Neonatal asphyxia Acromegaly Hyperphagia Pneumonia Systemic mastocytosis More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Basic Information Paroxysmal nocturnal haemoglobinuria – Diagnostics Haemophilia B with anti factor IX – Treatment Leiomyosarcoma recurrent – Diagnostics Malignant fibrous histiocytoma Pulmonary fibrosis – Trials in Disease Acquired haemophilia – Life with Disease Lennox-Gastaut syndrome Burkitt’s lymphoma Small intestine leiomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Certolizumab Pegol Keto-Leucine Calcium Ceftriaxone Candesartan Cilexetil Natalizumab Paracetamol Dc Azd5462 HRS 9531 Hyoscine Butylbromide Psilocybine Isotretinoin Abc-15A-116 Sertindole Purified Egg Phospholipids Camonsertib Pegunigalsidase Alfa Cefalexin Adrenaline Acid Tartrate Bp Desogestrel Elacestrant More therapies…

    Learn about Your Condition

    Chronic lymphocytic leukaemia Cerebral palsy Hypersensitivity Head injury Skin candida Malignant melanoma of eyelid Ischaemic skin ulcer Urticaria cholinergic Kidney transplant rejection Hypogonadism male Endocrine ophthalmopathy Carpal tunnel syndrome Von Hippel-Lindau disease Bone marrow failure Pancreaticoduodenectomy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of OG-6219 and Naproxen Sodium for Women Aged 18-49 with Moderate to Severe Endometriosis Pain

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Endometriosis
    Investigated Drugs:
    • For-6219
    • Naproxen Sodium
    Belgium Bulgaria Czechia France Germany Hungary +4

  • Study of Olezarsen (ISIS 678354) for Patients with High Triglycerides and Heart Disease or Severe High Triglycerides

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    • Arteriosclerosis
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Bulgaria Czechia Denmark Finland France Hungary +7

  • Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Isis 678354 Sodium Salt
    Belgium Bulgaria Czechia Denmark Finland France +13

  • Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiovascular disorder
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Andexanet Alfa
    • Apixaban
    • Milvexian
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13

  • Study on Linaclotide for Treating Functional Constipation in Children Aged 2 to 5 Years

    Not recruiting

    3 1
    Investigated Diseases:
    • Constipation
    Investigated Drugs:
    • Linaclotide
    Bulgaria The Netherlands

  • Study on Rifaximin for Delaying Hepatic Encephalopathy in Cirrhosis Patients

    Not recruiting

    3 1
    Investigated Drugs:
    • Rifaximin
    Belgium Bulgaria France Germany Hungary Italy +2

  • Study on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • (R)-1-(Tert-Butyl)-N-(8-(2-((1-Methyl-1H-Pyrazol-4-Yl)Amino)Pyrimidin-4-Yl)-2-(Oxetan-3-Yl)-2,3,4,5-Tetrahydro-1H-Benzo[C]Azepin-5-Yl)-1H-1,2,3-Triazole-4-Carboxamide
    • Diroximel Fumarate
    • Gadoteric Acid
    Bulgaria Czechia Germany Italy Poland Romania +1

  • Study on Inclisiran for Preventing Heart Disease in High-Risk Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Inclisiran
    Austria Belgium Bulgaria Croatia Czechia Denmark +14
Previous Page
1 … 17 18 19 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!